|
Olivier Charmeil is a graduate of HEC (Ecole des Hautes Etudes Commerciales) and of the Institut d’Etudes Politiques in Paris. From 1989 to 1994 he worked in the Mergers & Acquisitions department of Banque de l’Union Européenne. He joined Sanofi Pharma in 1994 as head of Business Development. Subsequently he held various posts within the Group including Chief Financial Officer (Asia) for Sanofi-Synthélabo in 1999 and Attaché to the Chairman Jean-François Dehecq in 2000 before being appointed as Vice President Development within the Sanofi-Synthélabo International Operations Directorate where he was responsible for China and support functions. In 2003 Olivier Charmeil was appointed Chairman and Chief Executive Officer of Sanofi-Synthélabo France before taking the post of Senior Vice President Business Management and Support within the Pharmaceutical Operations Directorate. In this role he piloted the operational integration of Sanofi-Synthélabo and Aventis. He was appointed to his current position in February 2006.
| 